Exhibitors and Sponsors

HFSA’s annual meeting has gained a reputation as an outstanding forum for presentation of the latest information available (clinical and basic research, treatment and care of patients) in the field of heart failure. We are expecting a strong attendance again this year. The 2017 conference was the one of the largest conferences, with nearly 2,000 attendees. What better venue to showcase your company’s products and services than at a meeting attended by the key thought leaders and decision makers in the field of heart failure. Don’t miss an opportunity to be a part of the only multidisciplinary meeting dedicated to heart failure. 

JUMP TO
2018 Exhibitors
Exhibiting Opportunities
Support Opportunities
Emerging Therapies Row

 2018 Exhibitors

Company Name Booth Number
Abbott 200
Abiomed, Inc. 312
AHA Get with the Guidelines – Heart Failure 324
Akcea Therapeutics 219
Alnylam Pharmaceuticals 307
American Association of Heart Failure Nurses 424
Amgen 513
Amyloidosis Foundation 519
Amyloidosis Research Consortium 112
Arbor Pharmaceuticals, LLC 314
Boston Scientific 214
CareDx, Inc. 106
CHF Solutions, Inc. 213
CMP Pharmaceuticals 207
Cytokinetics, Inc. 300
Daiichi Sankyo 514
Daxor Corporation 210
Getinge 206
Janssen Pharmaceuticals, Inc. 413
Medtronic 313
Mespere LifeSciences, Inc. 521
Miller Pharmacal Group, Inc. 208
Novartis Pharmaceuticals Corporation 400
Option Care 507
Pfizer 419
Preventice Solutions 319
Quest Diagnostics 512
Relypsa, Inc., A Vifor Pharma Group Company 407
Respicardia 108
RenalGuard Solutions, Inc. 415
Sensible Medical Innovations 412
Soleo Health 216
TAI Diagnostics, Inc. 418
TrueHelp, A Division of Allsup 109
VivaLNK, Inc. 218
Vyaire Medical 107
WomenHeart: The Coalition for Women with Heart Disease 325
Zoll LifeVest 110

   

Exhibiting Opportunities

The Exhibitor Prospectus is intended to provide information about the Heart Failure Society of America, the Annual Scientific Meeting, the individuals who attend the meeting, and why your company’s presence at the meeting will benefit your brand awareness. The rules and regulations in the document available for download are intended to serve the best interests of the Annual HFSA Scientific Meeting, the exhibitors and the registered attendees and to provide notice to applicants and exhibitors of governing rules and regulations. All are expected to abide by these rules and regulations.

The Exhibitor Prospectus contains:

  • General information and guidelines for exhibitors
  • Application for exhibit space
  • Preliminary floor plan
  • Unofficial event form
  • Booth activities form
  • Exhibitor application
  • and more…

Additional Information:

Relocation of Exhibits

HFSA reserves the right to alter locations of exhibits as shown on the official floor plan, if deemed, in the sole discretion of HFSA, to be advisable or in the best interests of HFSA.

Support Opportunities

The Heart Failure Society of America has numerous support opportunities for interested parties. The below Support Opportunities document  is intended to give exhibitors and industry partners a summary of the various ways they can present their company, product or services at the HFSA Annual Scientific Meeting. It is meant to be a starting point in generating ideas to work collaboratively with HFSA to create a successful presence at the meeting.

Additional Information & Applications:

Contemporary Forums

Contemporary Forums

These Non-CME educational forums take place in general session rooms (not the exhibit hall). Four opportunities are available for contemporary forums including:

  • Friday, September 14, evening
  • Saturday, September 15, early morning
  •  Sunday, September 16, evening
  • Monday, September 17, evening

Industry Contemporary Forums will be offered during any available time slot prior to or after daily HFSA Scientific Sessions and may coincide with another Industry Contemporary Forum or Satellite Symposium.

Industry Expert Theaters - SOLD OUT

Industry Expert Theaters – SOLD OUT

Industry Expert Theaters are Non-CME educational activities held in dedicated space in the exhibit hall. They allow industry experts an opportunity to provide clinical updates and educate attendees on current therapies, disease states, products and pipeline activities while remaining close to the action in the exhibit hall. Sessions are formatted for learning and are a great way to receive higher level interaction and engagement with company representatives.

Satellite Symposium

Satellite Symposium

The 2018 Heart Failure Society of America (HFSA) Satellite Symposium Guidelines provide a comprehensive guide to the requirements for holding a satellite symposium at the HFSA 22nd Annual Scientific Meeting, to be held September 15‐18, 2018, at the Gaylord Opryland Hotel & Convention Center in Nashville, Tennessee.

For questions, please contact HFSA Education Staff:
Shauna Brown, Director of Educational Programs at sbrown@hfsa.org or (301) 312‐8635 x229
Jaime Abreu, Executive Vice President, CME and Educational Programs at jabreu@hfsa.org or (301) 312‐8635 x224

Unofficial Events Application

Unofficial Events

HFSA reserves the right to control all contracted function space at the Gaylord Opryland Hotel and Convention Center for the 2018 22nd Annual Scientific Meeting. Unofficial events are restricted to registered scientific attendees and exhibitor staff. They are not planned or sponsored by HFSA. Hospitality rooms may not be open during the hours of any official HFSA function. The Gaylord Opryland Hotel and Convention Center will not release space without approval from HFSA. HFSA assumes no responsibility for property damage, personal injury or death to any party, by reason of occurrence at or related to such functions conducted. To avoid any confusion for individuals invited to participate in an unofficial event, the following paragraph is to be included in a visible area on the invitation: Although assignment of space to hold this unofficial event has been approved by the HFSA, the event has been planned and paid for by the organizer. This event is not affiliated with the HFSA, and HFSA has no responsibility for or liability with respect to the content or conduct of this unofficial event.

Signage will be allowed only in HFSA designated areas and must be approved by HFSA prior to display. Additional details and application form are located in the Support Opportunities Guide.

 

Emerging Therapies Row

Emerging Therapies Row is an exciting, new opportunity at this year’s HFSA meeting. For the first time, HFSA will provide a unique forum for companies early in development of diagnostics and therapies to the heart failure space to share information about their emerging products. Located in a designated focus area in the Exhibit Hall, each participating company will be provided with a small table top exhibit area to present their diagnostic or therapy.

Emerging Therapies Row Applications - Closed

Application Deadline: Closed

Tables may be staffed at any time during regular Exhibit Hall hours to answer questions. In addition, during peak exhibit hall hours, each company will be given a designated time where you can present a 3-5 slide overview of your company to drive direct meeting participants to your table for additional follow-up and discussions.

The event is taking place September 15 – September 18 at the Gaylord Opryland Hotel & Convention Center in Nashville Tennessee (click here to see event agenda). We believe this will be an important opportunity for emerging medical technology companies looking to:

  • Introduce your approach to physicians and identify potential FIH or other clinical trial sites
  • Obtain market research/input from a large number of experienced HF physicians in terms of clinical trial or device design
  • Get exposure to both small and large medical device companies for the purpose of potential investment and/or strategic partnership

More than 2,000 physicians, nurses and other health care related people are expected to attend the HFSA Scientific Sessions this year. This is an unparalleled opportunity for you to have rapid access to a large group focused primarily on heart failure.

Application Criteria

  1. Companies accepted for the Emerging Therapies Row should not already be performing a pivotal clinical trial for regulatory approval.
  2. Physicians with a bench prototype of a device are also eligible to apply for this opportunity.

Examples of information included at the exhibitor table:

  • Model or demonstration of your diagnostic or device
  • Videos to explain how diagnostic or device works
  • Company brochures
  • Other product information
  • Clinical trial outlines
  • Market research questionnaires

Publicity

All Emerging Therapy applications received by the deadline will be listed in the Annual Meeting final program book and on the meeting app.

Emerging Therapies Row information will be included in email announcements to pre-registrants regarding exhibit hall activities.

All Emerging Therapies Row companies will be displayed on the HFSA website following the Annual Meeting.

Cost: $1,000 (Industry Rate)

All other rules for exhibiting apply (for more information visit, meeting.hfsa.org/exhibitors). Payment must be received by July 14, 2018 to have submissions included in the HFSA Scientific Meeting program and posted on the exhibit hall floor. If you have questions, please contact Patrice Guzman at pguzman@hfsa.org or 301-312-8635. If interested, please complete this form and return it to pguzman@hfsa.org. You will be invoiced for payment.